Thyroid cancer: Biomarker landscape

Emmanuel Kwaku Ofori; Dziedzorm Wormenor

doi:10.1016/B978-0-443-33902-8.00007-9

Thyroid cancer: Biomarker landscape

Emmanuel Kwaku Ofori, Dziedzorm Wormenor

Department of Chemical Pathology

Paradise Diagnostic Centre

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

Thyroid cancer (TC) is the most prevalent endocrine-related malignancy. Significant breakthroughs in studying TC have provided a deeper understanding of the factors that either support or impede the effectiveness of therapy and control methods. Some significant biomarker breakthroughs have resulted in a more precise knowledge of the pathways responsible for TC. This chapter focuses mainly on the biomarker breakthroughs that have occurred in the detection and management of TC as well as the potential implications that these biomarkers may have for future advancements aimed at improving the detection and management of TC.

Original language	English
Title of host publication	Biomarker Landscape in Cancer Research
Publisher	Elsevier
Pages	269-290
Number of pages	22
ISBN (Electronic)	9780443339028
ISBN (Print)	9780443339035
DOIs	https://doi.org/10.1016/B978-0-443-33902-8.00007-9
Publication status	Published - 1 Jan 2025

Keywords

Biomarkers
Calcitonin
Immunoassay
Metabolomics
Midkine
Signaling
Thyroglobin
Thyroid cancer

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/B978-0-443-33902-8.00007-9

Cite this

@inbook{211c48923f7e43af85a70e3f68a6abc7,

title = "Thyroid cancer: Biomarker landscape",

abstract = "Thyroid cancer (TC) is the most prevalent endocrine-related malignancy. Significant breakthroughs in studying TC have provided a deeper understanding of the factors that either support or impede the effectiveness of therapy and control methods. Some significant biomarker breakthroughs have resulted in a more precise knowledge of the pathways responsible for TC. This chapter focuses mainly on the biomarker breakthroughs that have occurred in the detection and management of TC as well as the potential implications that these biomarkers may have for future advancements aimed at improving the detection and management of TC.",

keywords = "Biomarkers, Calcitonin, Immunoassay, Metabolomics, Midkine, Signaling, Thyroglobin, Thyroid cancer",

author = "Ofori, \{Emmanuel Kwaku\} and Dziedzorm Wormenor",

year = "2025",

month = jan,

day = "1",

doi = "10.1016/B978-0-443-33902-8.00007-9",

language = "English",

isbn = "9780443339035",

pages = "269--290",

booktitle = "Biomarker Landscape in Cancer Research",

publisher = "Elsevier",

}

TY - CHAP

T1 - Thyroid cancer

T2 - Biomarker landscape

AU - Ofori, Emmanuel Kwaku

AU - Wormenor, Dziedzorm

PY - 2025/1/1

Y1 - 2025/1/1

N2 - Thyroid cancer (TC) is the most prevalent endocrine-related malignancy. Significant breakthroughs in studying TC have provided a deeper understanding of the factors that either support or impede the effectiveness of therapy and control methods. Some significant biomarker breakthroughs have resulted in a more precise knowledge of the pathways responsible for TC. This chapter focuses mainly on the biomarker breakthroughs that have occurred in the detection and management of TC as well as the potential implications that these biomarkers may have for future advancements aimed at improving the detection and management of TC.

AB - Thyroid cancer (TC) is the most prevalent endocrine-related malignancy. Significant breakthroughs in studying TC have provided a deeper understanding of the factors that either support or impede the effectiveness of therapy and control methods. Some significant biomarker breakthroughs have resulted in a more precise knowledge of the pathways responsible for TC. This chapter focuses mainly on the biomarker breakthroughs that have occurred in the detection and management of TC as well as the potential implications that these biomarkers may have for future advancements aimed at improving the detection and management of TC.

KW - Biomarkers

KW - Calcitonin

KW - Immunoassay

KW - Metabolomics

KW - Midkine

KW - Signaling

KW - Thyroglobin

KW - Thyroid cancer

UR - https://www.scopus.com/pages/publications/105011233841

U2 - 10.1016/B978-0-443-33902-8.00007-9

DO - 10.1016/B978-0-443-33902-8.00007-9

M3 - Chapter

AN - SCOPUS:105011233841

SN - 9780443339035

SP - 269

EP - 290

BT - Biomarker Landscape in Cancer Research

PB - Elsevier

ER -

Thyroid cancer: Biomarker landscape

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this